FGHQF
Price
$0.10
Change
-$0.02 (-16.67%)
Updated
Jun 21 closing price
Capitalization
280.99M
HMTXF
Price
$0.11
Change
+$0.01 (+10.00%)
Updated
Jul 9 closing price
Capitalization
14.89M
Interact to see
Advertisement

FGHQF vs HMTXF

Header iconFGHQF vs HMTXF Comparison
Open Charts FGHQF vs HMTXFBanner chart's image
Frontage
Price$0.10
Change-$0.02 (-16.67%)
Volume$100K
Capitalization280.99M
Hemostemix
Price$0.11
Change+$0.01 (+10.00%)
Volume$11.96K
Capitalization14.89M
FGHQF vs HMTXF Comparison Chart in %
Loading...
HMTXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FGHQF vs. HMTXF commentary
Jul 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FGHQF is a Buy and HMTXF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 11, 2025
Stock price -- (FGHQF: $0.10 vs. HMTXF: $0.10)
Brand notoriety: FGHQF and HMTXF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FGHQF: 100% vs. HMTXF: 143%
Market capitalization -- FGHQF: $280.99M vs. HMTXF: $14.89M
FGHQF [@Biotechnology] is valued at $280.99M. HMTXF’s [@Biotechnology] market capitalization is $14.89M. The market cap for tickers in the [@Biotechnology] industry ranges from $314.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FGHQF’s FA Score shows that 0 FA rating(s) are green whileHMTXF’s FA Score has 1 green FA rating(s).

  • FGHQF’s FA Score: 0 green, 5 red.
  • HMTXF’s FA Score: 1 green, 4 red.
According to our system of comparison, HMTXF is a better buy in the long-term than FGHQF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HMTXF’s TA Score shows that 3 TA indicator(s) are bullish.

  • HMTXF’s TA Score: 3 bullish, 1 bearish.

Price Growth

FGHQF (@Biotechnology) experienced а 0.00% price change this week, while HMTXF (@Biotechnology) price change was -6.20% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +10.19%. For the same industry, the average monthly price growth was +16.32%, and the average quarterly price growth was +20.67%.

Industries' Descriptions

@Biotechnology (+10.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FGHQF($281M) has a higher market cap than HMTXF($14.9M). HMTXF YTD gains are higher at: 44.990 vs. FGHQF (0.000).
FGHQFHMTXFFGHQF / HMTXF
Capitalization281M14.9M1,886%
EBITDAN/A-2.79M-
Gain YTD0.00044.990-
P/E Ratio34.83N/A-
RevenueN/A0-
Total CashN/A965K-
Total DebtN/A4.69M-
FUNDAMENTALS RATINGS
HMTXF: Fundamental Ratings
HMTXF
OUTLOOK RATING
1..100
78
VALUATION
overvalued / fair valued / undervalued
1..100
4
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FGHQFHMTXF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
N/A
Bullish Trend 2 days ago
68%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
68%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
2%
Bullish Trend 2 days ago
64%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
2%
Bullish Trend 2 days ago
65%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
72%
View a ticker or compare two or three
Interact to see
Advertisement
HMTXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FIEZX13.59N/A
N/A
Fidelity Advisor Total Intl Equity Z
GSCLX30.32N/A
N/A
Goldman Sachs Large Cap Gr Insghts Svc
SGPIX108.93N/A
N/A
ProFunds Small Cap Growth Inv
CPTUX89.47N/A
N/A
Invesco Discovery Large Cap R5
MAIHX19.18N/A
N/A
Morgan Stanley Inst Passport ovrs eq IR

FGHQF and

Correlation & Price change

A.I.dvisor tells us that FGHQF and ANL have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FGHQF and ANL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FGHQF
1D Price
Change %
FGHQF100%
N/A
ANL - FGHQF
25%
Poorly correlated
-0.72%
SKYE - FGHQF
15%
Poorly correlated
-2.99%
LEXX - FGHQF
9%
Poorly correlated
+0.67%
HMTXF - FGHQF
8%
Poorly correlated
+4.40%
ZVRA - FGHQF
4%
Poorly correlated
+0.09%
More

HMTXF and

Correlation & Price change

A.I.dvisor tells us that HMTXF and DMAC have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HMTXF and DMAC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HMTXF
1D Price
Change %
HMTXF100%
+4.40%
DMAC - HMTXF
22%
Poorly correlated
+5.48%
BIVI - HMTXF
21%
Poorly correlated
-4.96%
AGEN - HMTXF
21%
Poorly correlated
+6.58%
DVHGF - HMTXF
21%
Poorly correlated
N/A
FDMT - HMTXF
12%
Poorly correlated
+4.74%
More